Mucinous (colloid) carcinoma of urinary bladder following long-term cyclophosphamide therapy for Waldenstrom's macroglobulinemia

American Journal of Surgical Pathology

Volumn 20, Issue 4, 1996, Pages 500-504

  Siddiqui, Anjum ^a,b   Melamed, Myron R ^a   Abbi, Rakesh ^a   Ahmed, Tauseef ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Colloid carcinoma; Cyclophosphamide; Urinary bladder; Waldenstrom's macroglobulinemia

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; MITOXANTRONE; PREDNISONE;

ACUTE MYELOBLASTIC LEUKEMIA; AGED; ARTICLE; AUTOPSY; BLADDER CARCINOMA; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COLLOID CARCINOMA; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; LABORATORY TEST; LONG TERM CARE; MEDICAL RECORD; MUCINOUS CARCINOMA; ORAL DRUG ADMINISTRATION; PHYSICAL EXAMINATION; URINARY TRACT INFECTION; WALDENSTROEM MACROGLOBULINEMIA;

ADENOCARCINOMA, MUCINOUS; AGED; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; NEOPLASMS, SECOND PRIMARY; URINARY BLADDER NEOPLASMS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0029964693     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199604000-00015     Document Type: Article

References (35)

1. Ansell ID, Castro JE. Carcinoma of the bladder complicating cyclophosphamide therapy. Br J Urol 1975;47:413-8.
2. Ansher AF, Melton JW, Sliwinsky AJ. Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis. Arthr Rheum 1983;26:804-5.
3. Baker GL, Kahl LE, Zee BC, et al. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case control follow-up study. Am J Med 1987;83: 1-9.
4. Brenner DW, Schellhammer PF. Upper tract urothelial malignancy after cyclophosphamide therapy: a case report and literature review. J Urol 1987;137:1226-7.
5. Cannon J, Linke CA, Cos LR. Cyclophosphamide associated carcinoma of urothelium: modalities for prevention. Urology 1991;38:413-6.
6. Chodak GW, Straus II FW, Shoenberg HW. Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion. J Urol 1981;125:424-6.
7. Cox, et al. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Phar 1979;28:2045-9.
8. Dale GA, Smith RB. Transitional cell carcinoma of the bladder associated with cyclophosphamide. J Urol 1974;112: 603-4.
9. Durkee C, Benson R Jr. Bladder cancer following administration of cyclophosphamide. Urology 1980;16:145-8.
10. Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis. J Urol 1984;131:960-2.
11. Elliott RW, Essenhigh DM, Mosely AR. Cyclophosphamide treatment of systemic lupus erythematous: Risk of bladder cancer exceeds benefit. Br Med J 1982;284:1161-2.
12. Fairchild WV, Spence R, Solomon HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979;122:163-4.
13. Forni AM, Koss LG, Geller W. Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man. Cancer 1964;17:1348-55.
14. Fuchs EF, Kay R, Poole R, et al. Uroepithelial carcinoma in association with cyclophosphamide ingestion. J Urol 1981; 126:544-5.
15. Garvin DD, Ball TP Jr. Bladder malignancy in patient receiving cyclophosphamide for benign disease. Urology 1981; 18:80-1.
16. Hakala TR et al. Antibody induction of lymphocyte mediated cytotoxicity against human transitional cell carcinomas of the urinary tract. N Engl J Med 1974;291:637-41.
17. Ito TY, Martin DC. Tumors of the bladder in renal transplant patients: report of a case of adenocarcinoma and review of known cases. J Urol 1977;117:52-3.
18. McDougal WS, Cramer SF, Miller R. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for non-malignant disease. Cancer 1981;48:691-5.
19. Moinuddin SM, Upton DW. Urological carcinoma after cyclophosphamide therapy. J Urol 1983;129:143-4.
20. O'Keane JC. Carcinoma of the urinary bladder after treatment with cyclophosphamide. N Engl J Med 1988;319:871.
21. Pearson RM, Soloway MS. Does cyclophosphamide induce bladder cancer? Urology 1978;11:437-47.
22. Pedersen-Bjergaard J, Ersboll J, Hansen L, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988;318: 1028-32.
23. Philips FS, Sternberg SS, Cronin AP, Vidal PM. Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961;21: 1572-89.
24. Plotz PH, Klippel JH, Decker JL, et al. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosis or rheumatoid arthritis. Ann Intern Med 1979;91:221-3.
25. Richtsmeier AJ. Urinary bladder tumors after cyclophosphamide [Letter to the Editor]. N Engl J Med 1975;293:1045-6.
26. Rowland RG, Eble JN. Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy. J Urol 1983;130:344-6.
27. Schiff HI, Finkel M, Schapira HE. Transitional cell carcinoma of the ureter associated with cyclophosphamide therapy for benign disease. A case report. J Urol 1982;128: 1023-4.
28. Schmahl D, Habs MR. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of Mesna. Cancer Treat Rev 1983;10(Suppl A): 57-71.
29. Seltzer SE, Benazzi RB, Kearney GP. Cyclophosphamide and carcinoma of bladder. Urology 1978;11:352-6.
30. Seo IS, Clark SA, McGovern FD, et al. Leiomyosarcoma of the urinary bladder 13 years after cyclophosphamide therapy for Hodgkin's disease. Cancer 1985;55:1597-1603.
31. Stein JP, Skinner EC, Boyd SD, Skinner DG. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of two cases. J Urol 1993;149:588-9.
32. Thrasher JB. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 1990;143:119-21.
33. Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 1975; 293:271-3.
34. Weinstein SH, Millerman LA, Schmidt JD. Cyclophosphamide [Letter to the Editor]. J Urol 1975;114:157.
35. Worth PHL. Cyclophosphamide and the bladder [Letter to the Editor]. Br Med J 1971;3:182.